PHASE-II STUDY OF RECOMBINANT ALPHA-2 INTERFERON IN RESISTANT MULTIPLE-MYELOMA

被引：99

作者：

COSTANZI, JJ

COOPER, MR

SCARFFE, JH

OZER, H

GRUBBS, SS

FERRARESI, RW

POLLARD, RB

SPIEGEL, RJ

机构：

[1] WAKE FOREST UNIV, BOWMAN GRAY SCH MED, WINSTON SALEM, NC 27103 USA

[2] UNIV MANCHESTER, MANCHESTER M13 9PL, LANCS, ENGLAND

[3] NEW YORK STATE DEPT HLTH, ROSWELL PK MEM INST, CTR CANC, BUFFALO, NY 14263 USA

[4] DARTMOUTH COLL, HITCHCOCK MED CTR, HANOVER, NH 03756 USA

[5] SCHERING CORP, KENILWORTH, NJ USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1985年 / 3卷 / 05期

关键词：

D O I：

10.1200/JCO.1985.3.5.654

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：654 / 659

页数：6

共 25 条

[11]

DURIE BGM, 1982, CLIN HAEMATOL, V11, P181

[12] LEUKOCYTE INTERFERON-INDUCED TUMOR-REGRESSION IN HUMAN METASTATIC BREAST-CANCER, MULTIPLE-MYELOMA, AND MALIGNANT-LYMPHOMA [J].

GUTTERMAN, JU ;

BLUMENSCHEIN, GR ;

ALEXANIAN, R ;

YAP, HY ;

BUZDAR, AU ;

CABANILLAS, F ;

HORTOBAGYI, GN ;

HERSH, EM ;

RASMUSSEN, SL ;

HARMON, M ;

KRAMER, M ;

PESTKA, S .

ANNALS OF INTERNAL MEDICINE, 1980, 93 (03) :399-406

[13]

LAKELEWIN D, 1979, CANCER TREAT REP, V63, P1403

[14]

MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163

[15]

MELLSTEDT H, 1979, LANCET, V1, P245

[16]

MELLSTEDT H, 1982, IMMUNOTHERAPY HUMAN, P387

[17]

MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO

[18]

2-6

[19] PRODUCTION AND PREPARATION OF HUMAN LEUKOCYTE INTERFERON [J].

MOGENSEN, KE ;

CANTELL, K .

PHARMACOLOGY & THERAPEUTICS PART A-CHEMOTHERAPY TOXICOLOGY AND METABOLIC INHIBITORS, 1977, 1 (04) :369-381

[20]

PRESANT CA, 1978, CANCER, V42, P1222, DOI 10.1002/1097-0142(197809)42:3<1222::AID-CNCR2820420329>3.0.CO

← 1 2 3 →